Open AccessSofosbuvir improves HCV‐induced insulin resistance by blocking IRS1 degradation
Author(s) -
Rey Esther,
Ampuero Javier,
MolinaJiménez Francisca,
Marañón Patricia,
GarcíaGarcía Yaiza,
MúñozHernández Rocío,
RomeroGómez Manuel,
GarcíaMonzón Carmelo,
Majano Pedro,
GonzálezRodríguez Águeda
Publication year - 2021
Publication title -
clinical and translational medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.275
Subject(s) - medicine , sofosbuvir , cirrhosis , insulin resistance , hepatitis c virus , ns5b , hepatitis c , diabetes mellitus , chronic infection , insulin , gastroenterology , ribavirin , immunology , hepacivirus , virus , endocrinology , immune system
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom